Disruptive pricing models are gaining momentum as the untapped opportunities drive incentives for manufacturers, payers and the patients that are served. Managing these emerging models requires the ability to reach the peak with revenue management excellence. There’s no doubt managing traditional pricing models accurately has a great impact on your GTN and business success. Imagine the magnitude of this critical function when you’re using one or more emerging models with complex terms and conditions.

Multiple sources of the “truth” simply cannot handle these complexities with transparency and accuracy. Without the ability to view pricing holistically with a single source of truth, how will this be reflected in your GTN accrual? 

3 emerging pricing models are at the forefront of Life Sciences negotiations and contain elements familiar to you from pricing models in other industries.